
TIQ-A
CAS No. 420849-22-5
TIQ-A( —— )
Catalog No. M28456 CAS No. 420849-22-5
TIQ-A is a PARP1 inhibitor which involved in DNA single-strand break repair via the base excision repair pathway. PARP1 is triggered by DNA damage and its excessive activation has been proposed as a causative factor in many pathological conditions including ischemia and reperfusion injury, asthma-related inflammation, and atherogenesis.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 147 | Get Quote |
![]() ![]() |
10MG | 260 | Get Quote |
![]() ![]() |
25MG | 484 | Get Quote |
![]() ![]() |
50MG | 691 | Get Quote |
![]() ![]() |
100MG | 888 | Get Quote |
![]() ![]() |
500MG | 1872 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameTIQ-A
-
NoteResearch use only, not for human use.
-
Brief DescriptionTIQ-A is a PARP1 inhibitor which involved in DNA single-strand break repair via the base excision repair pathway. PARP1 is triggered by DNA damage and its excessive activation has been proposed as a causative factor in many pathological conditions including ischemia and reperfusion injury, asthma-related inflammation, and atherogenesis.
-
DescriptionTIQ-A is a PARP1 inhibitor which involved in DNA single-strand break repair via the base excision repair pathway. PARP1 is triggered by DNA damage and its excessive activation has been proposed as a causative factor in many pathological conditions including ischemia and reperfusion injury, asthma-related inflammation, and atherogenesis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetPARP
-
RecptorErα|NF-κB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number420849-22-5
-
Formula Weight201.24
-
Molecular FormulaC11H7NOS
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (621.15 mM)
-
SMILESO=c1[nH]c2sccc2c2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
GeA-69
GeA-69 (GeA69) is a selective and allosteric PARP14 macrodomain 2 (MD2) inhibitor (Kd: 0.86 μM in ITC assays).
-
Talazoparib
Talazoparib (BMN 673) is a novel PARP inhibitor with IC50 of 0.58 nM.
-
Gemcabene calcium
Gemcabene (PD-72953, PD72953) is a first-in-class lipid-lowering agent and activator of PARP.